Recombinant erythropoietin for the treatment of iron deficiency anemia in pregnancy: A systematic review.

ABSTRACT:

Background

Treatment options for severe, refractory iron deficiency anemia are limited in pregnancy.

Objective

To review the available literature on the use of recombinant erythropoietin in the treatment of iron deficiency anemia in pregnancy.

Search strategy

An electronic search of seven databases from inception to March 2022 was performed using a combination of keywords.

Selection criteria

We included all randomized controlled or observational studies of pregnant patients with iron deficiency anemia who received recombinant erythropoietin or control. The primary outcome was a change in hematologic parameters (hemoglobin or hematocrit) after treatment. Studies were appraised using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interve

SUBMITTER: Levy AT 

PROVIDER: S-EPMC11649880 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature